JPRN-UMIN000006946已完成未知
Efficacy and safety of neoadjuvant CEX-XT treatment for triple-negative breast cancer - NeoXX trial
Department of breast and endocrine surgery, Hyogo college of medicine0 个研究点目标入组 40 人开始时间: 2012年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Another cancer diagnosed within 5 years 2. Pregnant or nursing women 3. Male patients 4. With history of serious drug allergy 5. With interstitial pneumonitis or lung fibrosis 6. Infection or possible infection associated with clinical symptoms such as fever 7. With symptom of varicella 8. With uncontrollable pleural effusion, or pericardial effusion 9. With severe edema 10. With severe peripheral neuropathy 11. Usual treatment with steroid 12. With severe psychological complication 13. Bilateral breast cancer 14. Cases who physician judged improper to entry this trial
研究者
相似试验
进行中（未招募）
1 期
XERXES: Examining the role of early neoadjuvant and synchronous Erbitux in pre-operative chemo-radiotherapy using Xeloda followed by excisional surgery. A phase I/II dose escalation study of intravenous erbitux (cetuximab) in combination with 5 day weekly oral Xeloda (capecitabine) and preoperative radiotherapy in rectal cancer. - XERXESocally advanced rectal cancerEUCTR2004-001926-26-GBniversity College London22
已完成
2 期
Effect of preoperative chemotherapy in the treatment of patients with locally advanced rectal cancerRectal cancer.Malignant neoplasm of rectumIRCT2016082129403N2Vice chancellor for research, Shiraz University of Medical Sciences40
招募中
1 期
eo-adjuvant combination chemotherapy of Tranilast in esophageal carcinomaJPRN-jRCTs051190076Shiozaki Atsushi59
已完成
2 期
Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer.Breast CancerJPRN-C000000345Japanese Foundation for Multidisciplinary Treatment of Cancer110
尚未招募
2 期
Combined neoadjuvant chemotherapy docetaxel (Taxotere), cisplatin and 5-Fluorouracil and concurrent chemoradiation in treating patients with locally advanced cancer of the larynxHead and neck cancerlaryngeal cancerCancer - Head and neckACTRN12610000856011Shiraz University of Medical Sciences50